Vaccine trials off to fast start for pandemic flu
Early Monday, Sarakas rolled up his sleeves for an injection in each arm, becoming one of dozens of adults enrolling in an unprecedented flurry of fast-track flu vaccine trials that will grow to include 11,131 adults and 5,740 children, with more trials planned.
Flu vaccines historically have few side effects beyond redness and soreness at the infection site. Studies of several thousand volunteers aren't big enough to detect more subtle side effects such as Guillain-Barré syndrome, a rare nerve ailment that crops up in one of every million flu vaccine recipients. Federal health agencies have ramped up surveillance efforts to detect any severe side effects that might occur.
Well, what a cozy little, "do as you're told, little mushrooms, if vaccination becomes mandatory piece" of propaganda!
As reported in
"In 1976 there was a swiner flu pandemic in the US and there was a vaccine offered. of those who decided to take it, one in ten died, and young people who took it were paralysed.
It could be contaminated. In the UK the company that is supplying a large proportion of the vaccines contaminated flu vaccines with live bird flu virus."
There is no way that the testing can fully vet the effectiveness - and side effects - of this vaccine before its deployment in the fall.
Also, as reported in:
"Adjuvants are added to vaccines to make them more “effective” and to reduce the amount of vaccine required per dose. They do this by causing your immune system to react in a powerful, unnatural and potentially dangerous way to the presence of the organism you’re being vaccinated against.
Squalene is proving to be among the worst of the worst in terms of immune adjuvants.
We know at least two of the swine flu vaccines under development by drug companies will contain the oil-based adjuvant squalene. Novartis and GlaxoSmithKline are producing those vaccines, and it’s probably just the tip of the iceberg because:
In a July 13 WHO swine flu pandemic briefing note in which they list their latest recommendations on vaccines, they state:
“In view of the anticipated limited vaccine availability at global level and the potential need to protect against "drifted" strains of virus, SAGE recommended that promoting production and use of vaccines such as those that are formulated with oil-in-water adjuvants and live attenuated influenza vaccines was important.”
Translation: WHO is now specifically recommending the production and use of vaccines containing oil-based adjuvants.
Also on July 13, HHS Secretary Sebelius committed another $884 million -- in addition to the $1 billion committed in May -- to purchase two key ingredients of the H1N1 vaccines under development. The key ingredients are:
1. The antigen (the active ingredient or organism)
2. The adjuvant
Novartis, whose vaccine contains the squalene adjuvant MF59, will receive $690 million of the $884 million.
Vaccine trials off to fast start for pandemic flu - USATODAY.com